Nasdaq:
ANIX
Home
About
Overview
Management Team
Board of Directors
Scientific Advisors
Breast Cancer Clinical Advisory Board
Cancer Business Advisory Board
Technologies
CAR-T
Introduction
Markets
Science
Collaborators
Cancer Vaccines
Introduction
Markets
Science
Collaborators
Breast Cancer Clinical Advisory Board
Pipeline
Investors
Overview
News Releases
Events & Presentations
Events
Corporate Presentation
Stock Information
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
SEC Filings
Financial Reports
Annual Reports
Quarterly Reports
Corporate Governance
Governance Documents
Committee Charters
News
Press Releases
Anixa In The News
Publications
YouTube Channel
Contact Us
News Releases
Investors
Investors
Overview
News Releases
Events & Presentations
Events
Corporate Presentation
Stock Info
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
Financial Reports
Annual Reports
Quarterly Reports
Governance
Governance Documents
Committee Charters
Investor Resources
Investor FAQs
Email Alerts
Fact Sheet
Contact IR
RSS News Feed
All News
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
Anixa Biosciences CAR-T Cancer Therapy Patent Receives Notice of Allowance
January 24, 2019
Anixa Biosciences to Hold Conference Call to Discuss Outlook for 2019
January 16, 2019
« Previous
1
2
3
4
5
Sign up for email Updates
Be The First to Receive Breaking News
Sign Up Now